What if the investigational new drug (IND) application was more than just a regulatory checkpoint—what if it served as your project’s strategic launchpad? In a new Applied Clinical Trials article, our Chief Medical and Scientific Officer, Michael Murphy M.D., Ph.D., discusses how reframing IND this way can help sponsors align scientific, regulatory, and business priorities across the drug development lifecycle right from the start. He explains how building a strong product narrative early can de-risk key decisions and lay the foundation for both clinical and business success. Interested in learning more about how a strategic approach to the pre-IND/IND process can turn a promising therapeutic candidate into a true corporate asset? Read the article here: https://ow.ly/9B2050XttOA #ClinicalTrials #ClinicalDevelopment #RegulatoryStrategy #DrugDevelopment #Pharma
Worldwide Clinical Trials
Research Services
Research Triangle Park, NC 209,315 followers
As a leading full-service global CRO, we work to create solutions that advance new treatments from discovery to reality.
About us
Worldwide Clinical Trials (Worldwide) is a full-service, global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new medications – from discovery to reality. Worldwide’s capabilities include bioanalytical laboratory services, Phase I-IV clinical trials, post-approval and real-world evidence studies – all powered by an accessible team of clinicians, scientists, and researchers who bring first-hand expertise and a collaborative, personalized approach to each clinical program. Worldwide is therapeutically focused on neuroscience, oncology, rare disease, cardiometabolic, and immune-mediated inflammatory diseases. Its global footprint spans over 60 countries with more than 3,500 team members. For more information on Worldwide, visit www.worldwide.com.
- Website
-
http://www.worldwide.com
External link for Worldwide Clinical Trials
- Industry
- Research Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Research Triangle Park, NC
- Type
- Privately Held
- Founded
- 1986
- Specialties
- Neuroscience/Central Nervous System Clinical Research, Rare Disease Clinical Research, Oncology Clinical Research, IMID Clinical Research, Cardiovascular and Metabolic Clinical Research, Cell and Gene Therapy, Global & Local Regulatory Support, Phase I Clinical Research, Trial Optimization, Quality Assurance, Protocol Development & Feasibility, Health Equity, Diversity and Inclusion, Drug Safety & Pharmacovigilance, Bioanalytical Lab, Clinical Pharmacology Unit, On-Site Pharmacy, and Medical Writing
Locations
Employees at Worldwide Clinical Trials
-
Karen Clagett
Team Lead, Talent Acquisition at Worldwide Clinical Trials | Candidate Experience Champion | Global Hiring Strategy | Driving Scalable Hiring…
-
David Bowser
Chief Operating Officer at Worldwide Clinical Trials
-
Glenn Sward
Vice President, Talent Acquisition and Development
-
Valerie Moss
Updates
-
When a challenging Phase I rare disease study needed a new direction, we stepped in. By implementing a strategic patient-focused approach, our team was able to exceed recruitment goals, leave a positive impression on study participants, and deliver exceptional results. Discover how our personalized approach contributed to this success. ➡️ https://ow.ly/Wity50XumqG...
-
-
Rare diseases are a profound journey, and the patients and families that belong to this community are the heart of a revolution ❤️ At our recent #RallyForRare documentary screening for "RARE: A Rare Disease Revolution" that was held at the Broad Institute of MIT and Harvard, we asked our panelists if they had a message they thought was important for the rare disease community. Hear what Johanna Mondesir, Winston Yan, MD PhD, and Tim Yu had to say 🔽
-
What does true patient advocacy look like in clinical research? Simran Padam, MD, APMMC (Padamology), Senior Medical Director at Worldwide, shares what it means to advocate for patients, and how empathy, patience and representation can lead to improved access, care, and results. Watch the full breakdown below. 👇
-
Join the Worldwide team at this year’s CTAD (Clinical Trials on Alzheimer’s Disease) on December 1-4 in San Diego. Connect, collaborate, and learn more about the advancements in Alzheimer’s disease diagnostics and therapeutics. Plus, hear from Worldwide’s very own Paula Penney, Executive Director, Project Management, Alzheimer’s Disease and other Dementias, who brings 20 years of experience leading global teams and improving patient care. Register now: https://ow.ly/7Bui50XsYb2
-
-
Site networks are redefining what’s possible in oncology clinical trials— but they’re not a one-size-fits-all. In this new MedCity News article by Matt Cooper and Scott Palmese, we unpack four key characteristics sponsors should examine to ensure site networks align with the strategic goals of their oncology studies. Read it here 👉 https://ow.ly/lCyL50XsXOQ
-
-
Worldwide is on the move! 🌍 Worldwide is joining biotech and pharma leaders from around the world at Clinical Trials in Oncology & Rare Diseases Europe. If you’re attending, stop by Booth 35 to connect and collaborate with our team. Don’t miss Matt Cooper as he presents “CAR-T Crossroads: Oncology Insights Driving Rare Disease Innovation,” where they will share insights from CAR-T trials and how it’s shaping the future of oncology. Register here 👉 https://ow.ly/j4SF50XowFI
-
Join us in welcoming Angel Uriol, Worldwide’s new Vice President of Therapeutic Strategy & Client Engagement, Oncology! 👏 With over 30 years of experience in pharmaceuticals and late-stage oncology research and development, Angel brings deep expertise in portfolio management, cross-functional team leadership, and business development. He previously held senior leadership roles guiding global oncology programs, overseeing numerous Phase IIb-IIIb trials across multiple cancer indications, and supporting key regulatory submissions that helped advance new therapies to patients. We’re thrilled to have you on board, Angel! Learn more about his expertise here ➡️ https://lnkd.in/ehCVcCDA
-
-
Join us in celebrating World Quality Week! Quality is at the heart of everything we do at Worldwide. We embed quality by design into our processes to ensure compliance, data integrity, and participant safety—always striving to exceed expectations. ➡️https://lnkd.in/ehV2VXD3 #QualityCulture #ClinicalResearch
Executive Vice President Global Quality Assurance @ Worldwide Clinical Trials | Leadership | Change Management | MTOPRA | MRQA
Happy World Quality Week! 🌍 From November 10–14, we celebrate the people and practices that build trust, drive innovation, and create lasting value. This year’s theme, “Quality: Think Differently,” challenges us to break old assumptions and explore new ways to elevate performance. At Worldwide Clinical Trials we’re raising the bar—streamlining processes, embracing technology, and strengthening partnerships to deliver better outcomes for team members and customers globally. Join me celebrating those who model curiosity, courage, and collaboration every day! #WQW25 #QualityMatters #ThinkDifferently
-
Join us at Pharma Clinical Innovation 2025 and learn how we’re shaping the next era of patient access in clinical research. Scott Palmese, Executive Director of Site-Focused Solutions at Worldwide Clinical Trials will host a workshop, “Reaching Patients in a Competitive Market: Innovative Site-Centric Approaches to Improving Patient Access to Clinical Trials.” Hear how site-centric strategies can expand access and drive more inclusive participation! Register here 👉 https://ow.ly/LI8f50XqyVI Reuters Events #REclinicalUSA